培生 PSO 深 滬

Immutep Outlines Focused Development Strategy for Eftilagimod Alfa (“efti”)

Immutep Limited announced updates on its eftilagimod alfa (efti) development strategy, focusing on head and neck squamous cell carcinoma (HNSCC) in PD-L1 negative patients (CPS < 1) and the neoadjuvant setting of soft tissue sarcoma (STS). A root cause analysis following the discontinuation of the TACTI-004 study identified manufacturing differences between efti produced at 200 L and 2,000 L scales, leading to a new 200 L manufacturing run. The c...

09-11 12:00

Citigroup Downgrades Pearson to Neutral

Citigroup analyst Ciaran Donnelly downgrades Pearson (NYSE:PSO) from Buy to Neutral.

09-03 02:35

Nutanix Gives Enterprises the Freedom to Run Production Agentic AI Their Way

08-26 13:00

Mission Produce® to Release Fiscal Third Quarter 2026 Financial Results on Tuesday, September 8, 2026

Mission Produce, Inc. announced it will release its fiscal third-quarter 2026 financial results on September 8, 2026, after market close, followed by a conference call and webcast at 5:00 PM Eastern Time. The call can be accessed via phone or webcast, with replay options available until September 22. Mission Produce is a global leader in fresh Hass avocados and other produce, with a diverse supply network and distribution capabilities worldwide.

08-25 20:05

Allied Gold Announces Addition of Joanna Pearson to Board of Directors

Allied Gold Corporation has appointed Joanna Pearson as an independent director, effective immediately. With over 25 years of experience in financial reporting, risk management, and strategic financial transformation in the mining sector, Pearson brings significant expertise to the Board. She previously served as CFO of Endeavour Mining plc and as an Audit Partner at Deloitte LLP. Her加入 will support Allied Gold's transition from the development s...

08-18 21:00

Skye Bioscience and Redx Pharma Announce Transaction Agreement and $125 Million in Financings

Skye Bioscience and Redx Pharma have entered into a definitive transaction agreement to merge, forming Fibrx Therapeutics, a fibrosis-focused company. The combined entity will trade on Nasdaq and is backed by $125 million in financing, aiming to fund operations through 2029. Fibrx’s lead program, RXC008, a GI-restricted pan-ROCK inhibitor for fibrostenotic Crohn’s disease, is set to begin a Phase 2 clinical trial with topline data expected in H2 ...

08-14 13:33

培生(PSO)上半年营收17.79亿英镑 AI落地及收购推进业务发展

经济观察网 培生（PSO）2026年上半年收入17.79亿英镑，同比增长4%，调整后营业利润同比增长14%，AI嵌入推动效率提升，收购K-12数字课程平台推进生...

08-08 23:15

Mission Produce® to Host Investor Day on October 8, 2026

Mission Produce, a global leader in fresh Hass avocados, will host an Investor Day in New York City on October 8, 2026. The event will focus on the company’s strategic priorities and long-term growth plans following its acquisition of Calavo Growers and the transition of John Pawlowski to CEO. Presentations from senior leadership and a Q&A session will be featured. A live webcast and replay will be available on the company’s investor relations we...

08-07 12:00

Safe Harbor's Cannabis-Focused 401(k) Plan Gains Early Adoption as Canopy HR Names It the Recommended Retirement Solution for its Clients

Safe Harbor, a fintech platform serving the cannabis industry, has launched a new Multiple Employer 401(k) Plan, attracting six new clients, including a multistate operator. Canopy HR, an HR provider for the cannabis industry, has endorsed the plan, validating its design and compliance framework. The plan addresses the industry's need for accessible retirement benefits, often challenging due to traditional providers' reluctance to serve cannabis ...

08-06 12:00

高盛下调评级后，培生集团股价下跌2%。

高盛下调评级后，培生集团股价下跌2%。

08-04 15:16